NOVOGEN INSISTS SALES ARE ON THE UP

Drug developer Novogen Ltd has posted another annual loss but says sales are on the up as the impact of new marketing strategies takes hold. Novogen reported a net loss of $11.13 million for 2004/05, compared to a loss of $10.9 million the previous year.

Revenue rose 7.5 per cent to $17.68 million, helped by greater promotion of its products and strong distribution channels in Australasia, European Union and United States.

Ninemsn (http://news.ninemsn.com.au/article.aspx?id=5149)